<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9"
        xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://www.rizerecovery.com/newsroom/samhsa-248-million-awards-peer-recovery-line-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-06T13:47:41.524Z</news:publication_date>
      <news:title>SAMHSA&apos;s $248 Million Goes Mostly to Institutions. The Peer-Led Recovery Line Got $1.4 Million.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/massachusetts-kratom-schedule-i-withdrawal-gap-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-06T13:47:38.286Z</news:publication_date>
      <news:title>Massachusetts Banned Kratom Overnight. The People Using It to Stay Off Opioids Got a Withdrawal and No Plan.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/youth-opioid-medication-retention-jama-network-open-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-06T13:47:34.928Z</news:publication_date>
      <news:title>Half of Young People With Opioid Addiction Make It Through the Door. One in 32 Is Still on Medication Six Months Later.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/medetomidine-withdrawal-naloxone-icu-what-providers-need-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T13:48:20.776Z</news:publication_date>
      <news:title>Naloxone Won&apos;t Touch Medetomidine. The Withdrawal That Follows Can Land Someone in the ICU for Weeks.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/no-approved-stimulant-drug-contingency-management-works-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T13:48:17.560Z</news:publication_date>
      <news:title>Three Hundred and Seventy-One Trials Later, There Is Still No Approved Drug for Meth or Cocaine. The Best Treatment We Have Is a Gift Card.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/nicotine-pouches-withdrawal-searchlights-fda-authorizations-spotlight-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T13:48:14.303Z</news:publication_date>
      <news:title>The FDA Keeps Clearing Nicotine Pouches. The Writer Who Quit One Cold Turkey Saw Searchlights.</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://www.rizerecovery.com/newsroom/one-in-32-young-people-opioid-medication-six-months-2026</loc>
    <news:news>
      <news:publication>
        <news:name>Rize Newsroom</news:name>
        <news:language>en</news:language>
      </news:publication>
      <news:publication_date>2026-10-05T13:48:10.930Z</news:publication_date>
      <news:title>Only 1 in 32 Young People With Opioid Addiction Is Still on Medication Six Months Later. The Treatment Didn&apos;t Fail Them.</news:title>
    </news:news>
  </url>
</urlset>